01 — Identify the product
Look for cell type, source, manufacturing, quality controls and route of administration rather than relying on the term cell therapy.
Wellness & Longevity · NK Cells
Natural killer (NK) cells are white blood cells in innate immunity that help recognize infected or abnormal cells. NK-cell therapy is a cellular technology whose source, manufacturing, indication and product-specific evidence must be considered separately.
iCell-therapy information must be assessed by the specific product, indication and available evidence.
Ask for more information
General health information
NK cell therapy is not the same as general immune support. Cell source, manufacturing and indication must be known.
Much NCI evidence relates to trials in specific cancers, not anti-aging or prevention in healthy people.
General health information
“Cell therapy” covers many different technologies. Benefits and risks cannot be inferred from the cell name alone.
Cells may come from the individual or a donor
Isolation, expansion, modification and quality-control processes differ
Evidence must match the specific condition, indication and product studied
Early research findings are not the same as an established benefit in routine use
General health information
Laboratory research, clinical trials and authorized medical uses should be considered as distinct levels of evidence.
Look for cell type, source, manufacturing, quality controls and route of administration rather than relying on the term cell therapy.
Ask which condition was studied, the trial phase and whether the measured outcome is meaningful to patients.
Review uncertainty, adverse effects, established alternatives and follow-up before making a decision.
General health information
General health information
Cell products can have different risks, and evidence from one product cannot automatically be applied to another.
Be cautious of claims to treat many diseases, reverse aging, restore the whole body or guarantee results without clearly naming the product, indication, evidence and risks.

The Beautier Clinic approach
EVIDENCE FIRST
Beautier Clinic provides this information to help distinguish biological knowledge, research and medical use from marketing claims.
A cell name is not enough; source, manufacturing, product and indication all matter.
Early research can provide initial information without establishing a benefit for routine use.
Balanced information includes limitations, risks, alternatives and what remains unknown.
FAQ
No. It is a complex cellular therapy requiring product-specific evidence and indication.
That should not be claimed from current evidence; much research is early-stage and cancer-specific.
EVIDENCE FIRST
The Beautier Clinic team can help explain terminology, sources and questions to verify without promising outcomes or replacing individualized medical advice.
Ask for more information
Chat with us